完整後設資料紀錄
DC 欄位語言
dc.contributor.authorCai, Yueeen_US
dc.contributor.authorZhang, Jinmingen_US
dc.contributor.authorChen, Nelson G.en_US
dc.contributor.authorShi, Zhien_US
dc.contributor.authorQiu, Jiangeen_US
dc.contributor.authorHe, Chengweien_US
dc.contributor.authorChen, Meiwanen_US
dc.date.accessioned2018-08-21T05:54:08Z-
dc.date.available2018-08-21T05:54:08Z-
dc.date.issued2017-07-01en_US
dc.identifier.issn0198-6325en_US
dc.identifier.urihttp://dx.doi.org/10.1002/med.21422en_US
dc.identifier.urihttp://hdl.handle.net/11536/145609-
dc.description.abstractTannins, polyphenols in medicinal plants, have been divided into two groups of hydrolysable and condensed tannins, including gallotannins, ellagitannins, and (-)-epigallocatechin-3-gallate (EGCG). Potent anticancer activities have been observed in tannins (especially EGCG) with multiple mechanisms, such as apoptosis, cell cycle arrest, and inhibition of invasion and metastases. Furthermore, the combinational effects of tannins and anticancer drugs have been demonstrated in this review, including chemoprotective, chemosensitive, and antagonizing effects accompanying with anticancer effect. However, the applications of tannins have been hindered due to their poor liposolubility, low bioavailability, off-taste, and shorter half-life time in human body, such as EGCG, gallic acid, and ellagic acid. To tackle these obstacles, novel drug delivery systems have been employed to deliver tannins with the aim of improving their applications, such as gelatin nanoparticles, micelles, nanogold, liposomes, and so on. In this review, the chemical characteristics, anticancer properties, and drug delivery systems of tannins were discussed with an attempt to provide a systemic reference to promote the development of tannins as anticancer agents. (C) 2016 Wiley Periodicals, Inc.en_US
dc.language.isoen_USen_US
dc.subjecttanninsen_US
dc.subjectanticanceren_US
dc.subject(-)-epigallocatechin-3-gallateen_US
dc.subjectcombinatorial effectsen_US
dc.subjectdrug delivery systemsen_US
dc.titleRecent Advances in Anticancer Activities and Drug Delivery Systems of Tanninsen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/med.21422en_US
dc.identifier.journalMEDICINAL RESEARCH REVIEWSen_US
dc.citation.volume37en_US
dc.citation.spage665en_US
dc.citation.epage701en_US
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000402965100001en_US
顯示於類別:期刊論文